Press Conference: Launching World's First Antimicrobial Resistance Benchmark   a0W0X00000AfRVSUA3
Channel: World Economic Forum
Date: 2018-01-23

More than 700,000 people already die every year from drug-resistant bacterial infections. Unless action is taken, this number will reach 10 million people a year worldwide by 2050 (more than currently die from cancer). Pharmaceutical companies, together with governments and other stakeholders, have a crucial role in preventing this scenario. 

The first-ever Antimicrobial Resistance Benchmark will map the actions of 30 pharmaceutical companies across three research areas: Research & Development, Manufacturing and Production, Access & Stewardship. The Benchmark will show where the pharmaceutical industry is taking action, which companies are leading, and where faster progress is needed.

Speakers:
- Julian Braithwaite, Ambassador and Permanent Representative of the United Kingdom to the United Nations and other International Organizations, Geneva.
- Jeremy Farrar, Director, Wellcome Trust, United Kingdom.
- Jayasree K. Iyer, Executive Director, Access to Medicine Foundation, Netherlands.
-Paul Stoffels, Executive Vice-President and Chief Scientific Officer, Johnson & Johnson, USA.

Moderator:
-Georg Schmitt, Head of Corporate Affairs, World Economic Forum.

http://www.weforum.org/